home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Exploitation Of Race As A Marketing Tool?

  December, 21 2006 2:10
your information resource in human molecular genetics
The obstacles facing the development of genetics-based personalized medicine are described online in Clinical Pharmacology & Therapeutics. Sandra Soo-Jin Lee highlights the problematic use of race and ethnicity as classification tools for genetically distinct populations.

Pharmacogenomics requires classifying people into populations based on genetics. Pharmaceutical companies and the FDA (Food and Drug Administration) have already set a trajectory for the development of race-based drugs. But researchers and practitioners have no standard system to define race and ethnicity. Furthermore, the racial categories that exist do not fit neatly with the range of human genetic differences. Despite these problems, marketing medications to specific populations remains easy and attractive to the pharmaceutical industry. This raises several concerns over the exploitation of race as a marketing tool. Individuals will be led to believe that certain drugs are tailored to them in the absence of sufficient supporting scientific data.

The author argues that addressing the issue of the role of race in the search for effective drugs is critical to the development of pharmacogenomics.

Author contact:

Sandra Soo-Jin Lee (Stanford University School of Medicine, Palo Alto, CA, USA)
E-mail: sandra.lee@stanford.edu

Editorial contact:

Carrie Nathans (Clinical Pharmacology & Therapeutics)
E-mail: cpt@ascpt.org

Full text available online.

(C) Clinical Pharmacology & Therapeutics press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.